Ki-67 Antigen

"Ki-67 Antigen" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A CELL CYCLE and tumor growth marker which can be readily detected using IMMUNOCYTOCHEMISTRY methods. Ki-67 is a nuclear antigen present only in the nuclei of cycling cells.

Descriptor ID	D019394
MeSH Number(s)	D12.776.660.625.500 D23.050.290.500 D23.101.140.400
Concept/Terms	Ki-67 Antigen Ki-67 Antigen Antigen, Ki-67 Ki 67 Antigen Antigen Ki-67 Antigen Ki 67 Ki-67, Antigen MIB-1 Antigen Antigen, MIB-1 MIB 1 Antigen MIB-1 Protein MIB 1 Protein Antigen Ki67 Ki67, Antigen

Below are MeSH descriptors whose meaning is more general than "Ki-67 Antigen".

Chemicals and Drugs [D]
Amino Acids, Peptides, and Proteins [D12]
Proteins [D12.776]
Nuclear Proteins [D12.776.660]
Antigens, Nuclear [D12.776.660.625]
Ki-67 Antigen [D12.776.660.625.500]
Biological Factors [D23]
Antigens [D23.050]
Antigens, Nuclear [D23.050.290]
Ki-67 Antigen [D23.050.290.500]
Biomarkers [D23.101]
Biomarkers, Tumor [D23.101.140]
Ki-67 Antigen [D23.101.140.400]

Below are MeSH descriptors whose meaning is more specific than "Ki-67 Antigen".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Ki-67 Antigen" by people in this website by year, and whether "Ki-67 Antigen" was a major or minor topic of these publications.

Bar chart showing 44 publications over 24 distinct years, with a maximum of 4 publications in 2007 and 2021

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	1	2	3
1998	0	2	2
1999	0	1	1
2000	0	2	2
2001	0	1	1
2002	2	0	2
2003	0	2	2
2004	1	0	1
2005	0	1	1
2006	0	1	1
2007	1	3	4
2008	0	1	1
2009	0	2	2
2010	0	2	2
2011	0	1	1
2012	1	0	1
2013	0	1	1
2014	0	2	2
2017	0	2	2
2018	1	1	2
2020	0	1	1
2021	1	3	4
2023	0	3	3
2025	1	1	2

Below are the most recent publications written about "Ki-67 Antigen" by people in Profiles.

Yarman Y, Post R, Breslin Z, Solomides CC, Gargano SM. Utility of Proliferation Markers Ki-67 and PHH3 in Predicting Malignancy in Basaloid Salivary Gland Neoplasms: A Study Using Digital Image Analysis of Cytology Cell Blocks. Diagn Cytopathol. 2025 May; 53(5):238-245.

View in: PubMed
Hrizat AS, Doxzon KA, O'Neill R, Post RP, Brachtel EF. Evaluation of HER2-Low breast carcinoma in metastatic settings: a cytological approach to proliferation and survival. J Am Soc Cytopathol. 2025 May-Jun; 14(3):182-190.

View in: PubMed
Lee YW, Ahn SH, Lee YJ, Yoo TK, Kim J, Chung IY, Kim HJ, Ko BS, Lee JW, Son BH, Lee SB. Survey of clinicians on the use of adjuvant therapy for premenopausal women with breast cancer. PLoS One. 2023; 18(8):e0290174.

View in: PubMed
Lee J, Lee YJ, Bae SJ, Baek SH, Kook Y, Cha YJ, Lee JW, Son BH, Ahn SH, Lee HJ, Gong G, Jeong J, Lee SB, Ahn SG. Ki-67, 21-Gene Recurrence Score, Endocrine Resistance, and Survival in Patients With Breast Cancer. JAMA Netw Open. 2023 08 01; 6(8):e2330961.

View in: PubMed
Khanna O, Fathi Kazerooni A, Arif S, Mahtabfar A, Momin AA, Andrews CE, Hafazalla K, Baldassari MP, Velagapudi L, Garcia JA, Sako C, Farrell CJ, Evans JJ, Judy KD, Andrews DW, Flanders AE, Shi W, Davatzikos C. Radiomic signatures of meningiomas using the Ki-67 proliferation index as a prognostic marker of clinical outcomes. Neurosurg Focus. 2023 06; 54(6):E17.

View in: PubMed
Song IH, Kim YA, Heo SH, Bang WS, Park HS, Choi YH, Lee H, Seo JH, Cho Y, Jung SW, Kim HJ, Ahn SH, Lee HJ, Gong G. The Association of Estrogen Receptor Activity, Interferon Signaling, and MHC Class I Expression in Breast Cancer. Cancer Res Treat. 2022 Oct; 54(4):1111-1120.

View in: PubMed
Khanna O, Fathi Kazerooni A, Farrell CJ, Baldassari MP, Alexander TD, Karsy M, Greenberger BA, Garcia JA, Sako C, Evans JJ, Judy KD, Andrews DW, Flanders AE, Sharan AD, Dicker AP, Shi W, Davatzikos C. Machine Learning Using Multiparametric Magnetic Resonance Imaging Radiomic Feature Analysis to Predict Ki-67 in World Health Organization Grade I Meningiomas. Neurosurgery. 2021 10 13; 89(5):928-936.

View in: PubMed
Prosniak M, Kenyon LC, Hooper DC. Glioblastoma Contains Topologically Distinct Proliferative and Metabolically Defined Subpopulations of Nestin- and Glut1-Expressing Cells. J Neuropathol Exp Neurol. 2021 08 11; 80(7):674-684.

View in: PubMed
Nowak-Choi K, Palmer JD, Casey J, Chitale A, Kalchman I, Buss E, Keith SW, Hegarty SE, Curtis M, Solomides C, Shi W, Judy K, Andrews DW, Farrell C, Werner-Wasik M. Resected WHO grade I meningioma and predictors of local control. J Neurooncol. 2021 Mar; 152(1):145-151.

View in: PubMed
Milman T, Zhang Q, Ang S, Elder D, Ida CM, Salomao DR, Lally SE, Shields JA, Hamershock RA, Sioufi K, Shields CL, Eagle RC. Conjunctival nevi and melanoma: multiparametric immunohistochemical analysis, including p16, SOX10, HMB45, and Ki-67. Hum Pathol. 2020 09; 103:107-119.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement